financetom
Business
financetom
/
Business
/
E-commerce & edtech have high growth potential, says JPMorgan’s Ankur Rudra
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
E-commerce & edtech have high growth potential, says JPMorgan’s Ankur Rudra
Dec 16, 2021 5:46 AM

In an interview to CNBC-TV18, Ankur Rudra, ED, Hd-APAC Telecoms Research-India Technology, Internet & Telecoms at JPMorgan said digitalization has become a very core part of our daily lives and the pandemic has definitely made it even more important.

He said, “Growth has never been a challenge, growth probably becomes a lot easier now. But the main thing the industry needs to figure out is what are the sustainable unit economics in every different part of the internet economy that we are looking at.”

Rudra said the sectors with higher frequency have a high potential for growth.

“Some of the sectors with higher frequency have a high potential for growth for example food delivery, e-grocery these are all sectors with a relatively high frequency which are relatively attractive. Education, again, it's a sector which has seen a significant amount of consolidation, it is a sector important from the propensity to pay perspective, so many sectors, I think, are very promising.”

For full interview, watch accompanying video...

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar
Summit Therapeutics' Ivonescimab Beats Merck's Therapy in Lung Cancer -- Shares Soar
May 30, 2024
03:46 PM EDT, 05/30/2024 (MT Newswires) -- Summit Therapeutics ( SMMT ) shares soared 137% in recent trading Thursday after the company shared results of ivonescimab meeting primary endpoint of progression-free survival to treat a type of lung cancer, beating Merck's ( MRK ) pembrolizumab. Results from the phase 3 trial showed that ivonescimab was statistically better at improving progression-free...
OpenAI responds to warnings of self governance by former board members, the Economist reports
OpenAI responds to warnings of self governance by former board members, the Economist reports
May 30, 2024
May 30 (Reuters) - OpenAI's board on Thursday pushed back on allegations from its former members that concerns over artificial intelligence safety at the startup necessitated Sam Altman's shocking ouster last year. OpenAI's board members in an article published in the Economist said the review into the events found the previous board's decision did not arise out of concerns over...
Exclusive-TikTok preparing a US copy of the app's core algorithm, sources say
Exclusive-TikTok preparing a US copy of the app's core algorithm, sources say
May 30, 2024
(Reuters) - TikTok is working on a clone of its recommendation algorithm for its 170 million U.S. users that may result in a version that operates independently of its Chinese parent and be more palatable to American lawmakers who want to ban it, according to sources with direct knowledge of the efforts. The work on splitting the source code ordered by...
WestJet Encore reaches tentative agreement with pilots
WestJet Encore reaches tentative agreement with pilots
May 30, 2024
May 30 (Reuters) - WestJet Encore has reached a tentative agreement with its pilots union over a new contract, the labor group said on Thursday, averting a strike at the Canadian regional carrier. (Reporting by Kannaki Deka in Bengaluru; Editing by Arun Koyyur) ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved